---
schema_version: "secwatch.filing_event.v1"
accession: "0001412408-22-000034"
form_type: "8-K"
ticker: "PHR"
cik: "0001412408"
company_name: "Phreesia, Inc."
filed_at: "2022-06-02T23:59:59+00:00"
generated_at: "2026-06-25T05:05:00.323381+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Phreesia Q1 revenue $63.4M (+31% YoY); FY23 Adj. EBITDA guidance raised to -$126M to -$122M

## Summary
- Revenue $63.4M vs $48.3M YoY; client count 2,526 (+33% YoY); avg. rev. per client $19,193 (-5% YoY).
- Adjusted EBITDA -$30.6M vs +$0.1M YoY; cash $269.2M, down $44.6M from Jan 2022.
- FY23 revenue outlook maintained $271M-$275M; Adj. EBITDA outlook raised to -$126M to -$122M from -$154M to -$149M.
- Company expects FY23 Adj. EBITDA to be low mark for FY23-FY25, targeting profitability in FY2025.
- Life sciences revenue $16.3M; patient payment volume $837M (+19% YoY).

## SEC filing metadata
- accession: 0001412408-22-000034
- form_type: 8-K
- ticker: PHR
- cik: 0001412408
- company_name: Phreesia, Inc.
- filed_at: 2022-06-02T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1412408/000141240822000034/0001412408-22-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1412408/000141240822000034/phr-20220602.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001412408-22-000034
- JSON: https://secwatch.observer/filing/0001412408-22-000034.json
- Plain text: https://secwatch.observer/filing/0001412408-22-000034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.